zh-twzhen
Contact Us
  • 繁
  • 簡
  • EN
  • ABOUT ONENESS
    • Company Info
    • Company Organization
    • History
    • Core Value & Business Philosophy
    • Team
    • Global Partnership
    • Nanchou Plant
    • CEO Conversation
    • Animal Center
  • SCIENCE
    • PIPELINE
    • R & D
      • ON101
      • FB825
      • FB704A
      • SNS812
      • SNS851
      • Research Publication/ Abstract
    • FESPIXON®
      • FESPIXON® Cream
      • About Diabetic Foot Ulcers
      • Expanded Access Program
      • Medical Subsidies for low-Income DFU Patients
      • Care for Diabetic Foot
      • The Ph3 Data and the Mechanism of Action of FESPIXON®(ON101)
      • FESPIXON® received International Innovation Awards from Enterprise Asia
    • Bonvadis®
    • Hospital Location
    • Health Education
      • Diabetic Foot Care
  • ESG
    • ESG Overview
      • Message from the Chairman
      • Sustainable Management Structure
      • Stakeholders Engagement and Material Topics
      • 2025 Sustainability Goals
      • Response to SDGs
      • ESG Awards and Highlights
    • Corporate Governance
      • Legal Compliance
      • Product Safety
      • Supply Chain Management
    • Environmental Protection
      • Environmental Management Systems
      • Climate Actions
      • Water Resources
      • Biodiversity
      • Chemical Substances and Waste Management
    • Social Inclusion
      • Diverse and Equal Workplace
      • Labor Rights
      • Talent Attraction, Retention, and Development
      • Healthy and Safe Working Environment
      • Access to Medicine
      • Social Engagement
    • ESG InfoHub
      • Latest ESG Report
      • Past ESG Reports
      • ESG Verification
      • Video Station
  • INVESTORS
    • Governance
      • Board of Directors
      • Functional Committee
      • Corporate Governance Officer Appointment
      • Internal Audit
      • Ethical Corporate Management
      • Risk Management
      • Cyber Security Management
      • Intellectual Property Management
      • Major Internal Policies
    • Shareholder Service
      • Annual Report
      • Shareholding Structure
      • Shareholder’s Meeting
      • Stock Quotes
      • Stock Dividend
      • Events & Presentations
      • Contact Audit Committee
    • Financial
      • Financial Report
      • Monthly Revenue
    • Investor FAQs
      • Investor Relations Contacts
  • NEWS
    • 2025
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
  • CAREER
    • Choose Oneness Biotech
    • Learning Development
    • Compensation & Benefits
    • Join Us
zh-twzhen
Contact Us
  • 繁
  • 簡
  • EN
  • ABOUT ONENESS
    • Company Info
    • Company Organization
    • History
    • Core Value & Business Philosophy
    • Team
    • Global Partnership
    • Nanchou Plant
    • CEO Conversation
    • Animal Center
  • SCIENCE
    • PIPELINE
    • R & D
      • ON101
      • FB825
      • FB704A
      • SNS812
      • SNS851
      • Research Publication/ Abstract
    • FESPIXON®
      • FESPIXON® Cream
      • About Diabetic Foot Ulcers
      • Expanded Access Program
      • Medical Subsidies for low-Income DFU Patients
      • Care for Diabetic Foot
      • The Ph3 Data and the Mechanism of Action of FESPIXON®(ON101)
      • FESPIXON® received International Innovation Awards from Enterprise Asia
    • Bonvadis®
    • Hospital Location
    • Health Education
      • Diabetic Foot Care
  • ESG
    • ESG Overview
      • Message from the Chairman
      • Sustainable Management Structure
      • Stakeholders Engagement and Material Topics
      • 2025 Sustainability Goals
      • Response to SDGs
      • ESG Awards and Highlights
    • Corporate Governance
      • Legal Compliance
      • Product Safety
      • Supply Chain Management
    • Environmental Protection
      • Environmental Management Systems
      • Climate Actions
      • Water Resources
      • Biodiversity
      • Chemical Substances and Waste Management
    • Social Inclusion
      • Diverse and Equal Workplace
      • Labor Rights
      • Talent Attraction, Retention, and Development
      • Healthy and Safe Working Environment
      • Access to Medicine
      • Social Engagement
    • ESG InfoHub
      • Latest ESG Report
      • Past ESG Reports
      • ESG Verification
      • Video Station
  • INVESTORS
    • Governance
      • Board of Directors
      • Functional Committee
      • Corporate Governance Officer Appointment
      • Internal Audit
      • Ethical Corporate Management
      • Risk Management
      • Cyber Security Management
      • Intellectual Property Management
      • Major Internal Policies
    • Shareholder Service
      • Annual Report
      • Shareholding Structure
      • Shareholder’s Meeting
      • Stock Quotes
      • Stock Dividend
      • Events & Presentations
      • Contact Audit Committee
    • Financial
      • Financial Report
      • Monthly Revenue
    • Investor FAQs
      • Investor Relations Contacts
  • NEWS
    • 2025
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
  • CAREER
    • Choose Oneness Biotech
    • Learning Development
    • Compensation & Benefits
    • Join Us

Annual Report

合一生技股份有限公司 / INVESTORS / Shareholder Service / Annual Report
  • Governance
    • Board of Directors
    • Functional Committee
    • Corporate Governance Officer Appointment
    • Internal Audit
    • Ethical Corporate Management
    • Risk Management
    • Cyber Security Management
    • Intellectual Property Management
    • Major Internal Policies
  • Shareholder Service
    • Annual Report
    • Shareholding Structure
    • Shareholder’s Meeting
    • Stock Quotes
    • Stock Dividend
    • Events & Presentations
    • Contact Audit Committee
  • Financial
    • Financial Report
    • Monthly Revenue
  • Investor FAQs
    • Investor Relations Contacts
    • FAQs (by Category)

Annual Report

Item Title
  • Loading...

Youtube

Linkedin

ADD: 35F., No. 66, Sec. 1, Zhongxiao W. Rd., Zhongzheng Dist., Taipei City, Taiwan (R.O.C.)

TEL: +886(0)2-2703-1098 (Taiwan) FAX : 02-2703-1200

(GMT+8 09:00-17:00 from Monday to Friday)

  • ABOUT ONENESS
    • Company Info
    • Company Organization
    • History
    • Core Value & Business Philosophy
    • Team
    • Global Partnership
    • Nanchou Plant
    • CEO Conversation
    • Animal Center
  • SCIENCE
    • PIPELINE
    • R & D
      • ON101
      • FB825
      • FB704A
      • SNS812
      • SNS851
      • Research Publication/ Abstract
    • FESPIXON®
      • FESPIXON® Cream
      • About Diabetic Foot Ulcers
      • Expanded Access Program
      • Medical Subsidies for low-Income DFU Patients
      • Care for Diabetic Foot
      • The Ph3 Data and the Mechanism of Action of FESPIXON®(ON101)
      • FESPIXON® received International Innovation Awards from Enterprise Asia
    • Bonvadis®
    • Hospital Location
    • Health Education
      • Diabetic Foot Care
  • ESG
    • ESG Overview
      • Message from the Chairman
      • Sustainable Management Structure
      • Stakeholders Engagement and Material Topics
      • 2025 Sustainability Goals
      • Response to SDGs
      • ESG Awards and Highlights
    • Corporate Governance
      • Legal Compliance
      • Product Safety
      • Supply Chain Management
    • Environmental Protection
      • Environmental Management Systems
      • Climate Actions
      • Water Resources
      • Biodiversity
      • Chemical Substances and Waste Management
    • Social Inclusion
      • Diverse and Equal Workplace
      • Labor Rights
      • Talent Attraction, Retention, and Development
      • Healthy and Safe Working Environment
      • Access to Medicine
      • Social Engagement
    • ESG InfoHub
      • Latest ESG Report
      • Past ESG Reports
      • ESG Verification
      • Video Station
  • INVESTORS
    • Governance
      • Board of Directors
      • Functional Committee
      • Corporate Governance Officer Appointment
      • Internal Audit
      • Ethical Corporate Management
      • Risk Management
      • Cyber Security Management
      • Intellectual Property Management
      • Major Internal Policies
    • Shareholder Service
      • Annual Report
      • Shareholding Structure
      • Shareholder’s Meeting
      • Stock Quotes
      • Stock Dividend
      • Events & Presentations
      • Contact Audit Committee
    • Financial
      • Financial Report
      • Monthly Revenue
    • Investor FAQs
      • Investor Relations Contacts
  • NEWS
    • 2025
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
  • CAREER
    • Choose Oneness Biotech
    • Learning Development
    • Compensation & Benefits
    • Join Us
Copyright © Oneness Biotech Co., Ltd.. All Rights Reserved.